BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1876-6250

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status ; day:2 ; month:2 ; year:2021 ; pages:1-8
Netherlands heart journal ; (2.2.2021), 1-8

Creator: Jansen, M.
Christiaans, I.
Crabben, S. N. van der
Michels, M.
Huurman, R.
Hoedemaekers, Y. M.
Dooijes, D.
Jongbloed, J. D. H.
Boven, L. G.
Lekanne Deprez, R. H.
Wilde, A. A. M.
Jans, J. J. M.
Velden, J. van der
Boer, R. A. de
Tintelen, J. P. van
Asselbergs, F. W.
Baas, A. F.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s12471-021-01539-w

URN: urn:nbn:de:101:1-2021032621505235264805

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jansen, M.
Christiaans, I.
Crabben, S. N. van der
Michels, M.
Huurman, R.
Hoedemaekers, Y. M.
Dooijes, D.
Jongbloed, J. D. H.
Boven, L. G.
Lekanne Deprez, R. H.
Wilde, A. A. M.
Jans, J. J. M.
Velden, J. van der
Boer, R. A. de
Tintelen, J. P. van
Asselbergs, F. W.
Baas, A. F.
SpringerLink (Online service)

Other Objects (12)

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness

Diagnosis and management of hypertrophic cardiomyopathy

Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study

Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers

A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness

Diagnosis and management of hypertrophic cardiomyopathy

Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study

Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers

A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness

Diagnosis and management of hypertrophic cardiomyopathy

Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study

Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers

A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness

Diagnosis and management of hypertrophic cardiomyopathy

Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study

Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers

A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness

Diagnosis and management of hypertrophic cardiomyopathy

Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study

Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers

A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness

Diagnosis and management of hypertrophic cardiomyopathy

Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study

Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers

A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects

Related objects

Reset password